AK Medical Buys JRI Orthopedics for $24M
AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK. Upon completion, JRI Orthopaedics will become a wholly-owned subsidiary of the Hong Kong Stock Exchange-listed AK Medical.
Founded in 1970 by orthopaedic surgeon Ronald Furlong, JRI Orthopaedics was the first company to produce a hip implant with a hydroxyapatite coating enabling a biological bond with the patient’s bone. Apart from hip implants, it also develops and distributes total shoulder replacement implants and a range of orthobiologics.
Prior to the acquisition, JRI Orthopaedics had already entered into an exclusive distribution deal with AK Medical’s cemented, unscented and revision hip product portfolio in China.
According to AK Medical, the acquisition is in line with its long-term growth plan and will help expand the company’s product portfolio to create a dual-brand strategy, enhance its R&D capabilities and access to the international market.
Looking for chemical products? Let suppliers reach out to you!
2026-07-20
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Maximum reduction of 81%! 22,000 down to $6,300 Large group of consumables with collective price cuts
-
Overview of China's medical device import and export trade in 2021
-
5 Billion! Strong Growth! Top 1 Sample Hospital Variety
-
Do You Know the Real Benefits of Eating Bird's Nest?
-
Polycarbonate PC turns out to have so many uses
-
Nation helping meet global demand for medical supplies
-
Yanan Petrochemical converted polypropylene medical non-woven fabric material
-
Medicare Payment: Grass-roots co-ordinated payment
-
Xinlitai heavy new product will be approved soon
-
The original research price of 3.5 billion pound varieties dropped by 74%
Recommend Reading
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Insufficient Support, May Butanol Prices in China Decrease by Nearly 10%
-
August Shandong n-Butanol Market First Falls, Then Rises
-
Trump’s Steel, Aluminum and Copper Tariff Changes Pull Chemical Manufacturing Into the Impact Zone
-
Supply Contraction Dominates, Melamine Market Stably Fluctuates
-
EU Plans Broader Quotas and Tariffs on China, With Chemicals Clearly Named